Cumberland Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8M Sell
31,490
-570
-2% -$133K 0.52% 44
2026
Q1
$7.84M Sell
32,060
-27,315
-46% -$6.36M 0.59% 37
2025
Q4
$12.3M Sell
59,375
-8,440
-12% -$1.67M 0.75% 30
2025
Q3
$12.6M Buy
67,815
+56,015
+475% +$9.6M 0.82% 29
2025
Q2
$1.8M Sell
11,800
-2,730
-19% -$420K 0.13% 107
2025
Q1
$2.41M Sell
14,530
-3,770
-21% -$590K 0.19% 90
2024
Q4
$2.65M Buy
18,300
+2,850
+18% +$442K 0.18% 82
2024
Q3
$2.5M Buy
15,450
+8,350
+118% +$1.33M 0.17% 83
2024
Q2
$1.04M Buy
7,100
+2,168
+44% +$322K 0.08% 127
2024
Q1
$780K Buy
+4,932
New +$785K 0.06% 144
2023
Q3
Sell
-8,679
Closed -$1.44M 184
2023
Q2
$1.44M Sell
8,679
-38
-0.4% -$6.13K 0.13% 104
2023
Q1
$1.35M Sell
8,717
-30,006
-77% -$4.85M 0.13% 97
2022
Q4
$6.84M Sell
38,723
-90,293
-70% -$15.6M 0.72% 30
2022
Q3
$21.1M Buy
129,016
+650
+0.5% +$110K 2.24% 16
2022
Q2
$22.8M Buy
128,366
+119,366
+1,326% +$21.3M 2.17% 17
2022
Q1
$1.6M Buy
9,000
+1,357
+18% +$231K 0.12% 99
2021
Q4
$1.31M Sell
7,643
-17,431
-70% -$2.85M 0.09% 118
2021
Q3
$4.05M Sell
25,074
-10,493
-30% -$1.79M 0.33% 75
2021
Q2
$5.86M Buy
35,567
+138
+0.4% +$22.8K 0.46% 59
2021
Q1
$5.82M Buy
35,429
+10,634
+43% +$1.72M 0.48% 59
2020
Q4
$3.9M Sell
24,795
-10,810
-30% -$1.6M 0.35% 71
2020
Q3
$5.3M Buy
35,605
+7,170
+25% +$1.06M 0.55% 56
2020
Q2
$4M Sell
28,435
-4,984
-15% -$726K 0.41% 63
2020
Q1
$4.38M Sell
33,419
-14,104
-30% -$2M 0.53% 48
2019
Q4
$6.93M Sell
47,523
-1,425
-3% -$193K 0.62% 50
2019
Q3
$6.33M Buy
48,948
+88
+0.2% +$11.6K 0.61% 51
2019
Q2
$6.8M Sell
48,860
-18,727
-28% -$2.59M 0.65% 46
2019
Q1
$9.45M Sell
67,587
-80,526
-54% -$10.8M 0.95% 35
2018
Q4
$19.1M Sell
148,113
-76,185
-34% -$10.6M 2.16% 17
2018
Q3
$31M Buy
224,298
+189,245
+540% +$25.1M 2.96% 8
2018
Q2
$4.25M Buy
+35,053
New +$4.37M 0.43% 53

Other funds holding JNJ

Cumberland Partners's JNJ Position: Q2 2026 in Review

Cumberland Partners reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q2 2026, selling an estimated $133K and leaving 31,490 shares worth $8M. The position accounts for 0.52% of the portfolio, ranked #44.

Cumberland Partners first reported a position in JNJ in Q2 2018 and has held it in 31 quarters since. The position peaked at $31M in Q3 2018. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cumberland Partners held 31,490 shares of Johnson & Johnson worth $8M as of Q2 2026.
  • Cumberland Partners sold 570 Johnson & Johnson shares in Q2 2026, an estimated $133K.
  • Johnson & Johnson made up 0.52% of Cumberland Partners's portfolio in Q2 2026, its #44 holding.
  • Cumberland Partners first reported a position in Johnson & Johnson in Q2 2018 and has held it in 31 quarters since.
  • Cumberland Partners's Johnson & Johnson position peaked at $31M in Q3 2018.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cumberland Partners's 13F filing for Q2 2026, filed 6 Aug 2026.